share_log

Kong Lam Buys Handful Of Shares In China Medical System Holdings

Kong Lam Buys Handful Of Shares In China Medical System Holdings

康南购买中国医疗系统控股有限公司少量股份
Simply Wall St ·  08/28 18:15

Potential China Medical System Holdings Limited (HKG:867) shareholders may wish to note that the Founder, Kong Lam, recently bought HK$3.6m worth of stock, paying HK$7.23 for each share. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

中国医疗系统控股有限公司(HKG:867)的潜在股东可能希望注意到,创始人Kong Lam最近购买了价值360万港元的股票,每股支付7.23港元。尽管这笔交易在百分比或绝对价值上都不算太大,但可以看作是一个好兆头。

China Medical System Holdings Insider Transactions Over The Last Year

中国医疗系统控股内部交易在过去一年内

In fact, the recent purchase by Founder Kong Lam was not their only acquisition of China Medical System Holdings shares this year. Earlier in the year, they paid HK$7.32 per share in a HK$7.3m purchase. That means that an insider was happy to buy shares at above the current price of HK$7.19. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Kong Lam was the only individual insider to buy shares in the last twelve months.

事实上,创始人Kong Lam最近的买入并不是他们今年对中国医疗系统控股的唯一买入。在年初,他们以7.32港元每股的价格购买了价值730万港元的股票。这意味着内部人士乐意以高于当前7.19港元的价格购买股票。他们的观点可能自那时起就已经改变,但至少表明他们当时感到乐观。对我们来说,考虑内部人士购买股票时的价格是非常重要的。一般来说,当内部人士以高于当前价格购买股票时,我们对股票的看法更为积极,因为这表明他们认为股票的价值较高,即使价格更高。Kong Lam是过去12个月内唯一一个买入股票的个人内部人士。

Kong Lam bought a total of 21.00m shares over the year at an average price of HK$7.05. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

Kong Lam在过去一年内以平均7.05港元的价格购买了2100万股。您可以在下面看到内部交易(由公司和个人)过去12个月的视觉呈现。如果您点击图表,就可以看到所有的个人交易,包括股价、个人和日期!

1724883338485
SEHK:867 Insider Trading Volume August 28th 2024
SEHK:867内部人交易成交量2024年8月28日

There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).

内部人士正在购买的股票是无数的。如果您喜欢投资于较少知名公司,您可以查看此免费的公司列表(提示:内部人士一直在购买它们)。

Insider Ownership Of China Medical System Holdings

中国医疗系统控股内部持股情况

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that China Medical System Holdings insiders own 51% of the company, worth about HK$8.9b. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

许多投资者喜欢查看公司被内部人持有的比例。通常来说,内部人持股比例越高,内部人就越有动力长期发展公司。很高兴看到中国医疗系统控股的内部人拥有公司51%的股份,价值约89亿港元。大多数股东都会乐意看到这种内部持股情况,因为这表明管理层的激励与其他股东的利益是一致的。

So What Does This Data Suggest About China Medical System Holdings Insiders?

那么这些数据对中国医药系统控股有限公司内部人员意味着什么?

It is good to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest China Medical System Holdings insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 2 warning signs with China Medical System Holdings and understanding them should be part of your investment process.

近期内部人购买股份情况看起来不错。对过去一年的交易进行分析也增加了我们的信心。当结合显著的内部持股情况时,这些因素表明中国医疗系统控股的内部人利益是相符的,很可能认为股价偏低。至少要加入自选名单!尽管了解内部人的持股和交易情况很重要,但在做出任何投资决定之前,我们一定要考虑股票面临的风险。在投资风险方面,我们已经发现了中国医疗系统控股的2个警示信号,了解这些信号应该是你投资过程的一部分。

Of course China Medical System Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,中国医疗系统控股可能不是最好的股票选择。因此,你可能希望看看这些高质量公司的免费收藏。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发